has been cited by the following article(s):
|
[1]
|
Increased Expression of AKT3 in Neuroendocrine Differentiated Prostate Cancer Cells Alters the Response Towards Anti-Androgen Treatment
Cancers,
2021
DOI:10.3390/cancers13030578
|
|
|
|
|
[2]
|
Treatment-Emergent Neuroendocrine Prostate Cancer: A Clinicopathological and Immunohistochemical Analysis of 94 Cases
Frontiers in Oncology,
2021
DOI:10.3389/fonc.2020.571308
|
|
|
|
|
[3]
|
PCa dynamics with neuroendocrine differentiation and distributed delay
Mathematical Biosciences and Engineering,
2021
DOI:10.3934/mbe.2021425
|
|
|
|
|
[4]
|
The regulation of HAS3 by miR-10b and miR-29a in neuroendocrine transdifferentiated LNCaP prostate cancer cells
Biochemical and Biophysical Research Communications,
2020
DOI:10.1016/j.bbrc.2020.01.026
|
|
|
|
|
[5]
|
The deregulation of miR-17/CCND1 axis during neuroendocrine transdifferentiation of LNCaP prostate cancer cells
PLOS ONE,
2018
DOI:10.1371/journal.pone.0200472
|
|
|
|
|
[6]
|
Neuroendocrine Transdifferentiation in Human Prostate Cancer Cells: An Integrated Approach
Cancer Research,
2015
DOI:10.1158/0008-5472.CAN-14-3830
|
|
|
|
|
[7]
|
SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer
Clinical Cancer Research,
2015
DOI:10.1158/1078-0432.CCR-15-0157
|
|
|
|